Product Categories
| Country: | China |
|---|---|
| Tel: | |
| Mobile: | +8613437178871 |
| E-mail: | 871796478@qq.com |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Rituximab | C6416H9874N1688O1987S44 | 174722-31-7 | Details |
| GLYCOCHOLIC ACID SODIUM SALT | C26H42NNaO6 | 863-57-0 | Details |
| 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, 2-[(4-isothiocyanatophenyl)methyl]- | C24H33N5O8S | 127985-74-4 | Details |
| Nicotinic acid | C6H5NO2 | 59-67-6 | Details |
| Tranilast | C18H17NO5 | 53902-12-8 | Details |
| Maleimide-DOTA | C22H34N6O9 | 1006711-90-5 | Details |
| 1-BENZYL-3-METHYLIMIDAZOLIUM HEXAFLUOROP | C11H13N2.F6P | 433337-11-2 | Details |
| CL2A-SN-38 | C73H97N11O22 | 1279680-68-0 | Details |
| Lipase | C11H9N3NaO2+ | 9001-62-1 | Details |
| Rosmarinic acid | C18H16O8 | 20283-92-5 | Details |
| Trevogrumab | 1429201-24-0 | Details |
| Zolbetuximab | 1496553-00-4 | Details |
| Meplazumab | 2413715-21-4 | Details |
| Nicotinamide | C6H6N2O | 98-92-0 | Details |
| Erucic Acid | C22H42O2 | 112-86-7 | Details |
| Magnesium L-Threonate | C8H14MgO10 | 778571-57-6 | Details |
| Trastuzumab emtansine | 1018448-65-1 | Details |
| Pembrolizumab | 1374853-91-4 | Details |
| Isonicotinic acid | C6H5NO2 | 55-22-1 | Details |
| Beer Yeast Hydrolysate | Details |
| Zein | N/A | 9010-66-6 | Details |
| 1-propyl-3-MethyliMidazoliuM chloride | C7H13ClN2 | Details |
| VcMMAE | C68H105N11O15 | 646502-53-6 | Details |
| Daratumumab | 945721-28-8 | Details |
| Immobilized D-Hydantoinace | Details |
| Lirilumab | 1000676-41-4 | Details |
| Spinosyn A | C41H65NO10 | 131929-60-7 | Details |
| Secukinumab | 875356-43-7 | Details |
| Deruxtecan | C52H56FN9O13 | 1599440-13-7 | Details |
| 4-Hydroxyisoleucine | C6H13NO3 | 21704-86-9 | Details |
| lomazone | C12H14ClNO2 | 81777-89-1 | Details |
| Crotedumab | 1452387-69-7 | Details |
| Rozanolixizumab | 1584645-37-3 | Details |
| Camrelizumab | 1798286-48-2 | Details |
| Nicotinamide riboside malate | C15H20N2O10 | 2415659-01-5 | Details |
| Litifilimab | 2407378-48-5 | Details |
| Immobilized cephalosporin C acylase | Details |
| Necitumumab | 906805-06-9 | Details |
| 1-propylsulfonic-3-MethyliMidazoliuM hydrogensulfate | C7H13N2O3S.HO4S | 916479-93-1 | Details |
| L-Threonic acid calcium salt | C8H14CaO10 | 70753-61-6 | Details |
| Vitamin D2 | C28H44O | 50-14-6 | Details |
| Vonlerolizumab | 1638935-72-4 | Details |
| 1-Methyl-3-(3-sulfopropyl)-1H-imidazol-3-ium chloride | C7H13N2O3S.Cl | 1034558-51-4 | Details |
| PERESOLIMAB | 2411580-63-5 | Details |
| Fondaparinux sodium | C31H43N3O49S8.10Na | 114870-03-0 | Details |
| 2-[[(2,3-Difluorophenyl)methyl]thio]-N-[1-(2-methoxyethyl)-4-piperidinyl]-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1(4H)-quinolineacetamide | C40H38F5N3O3S | 412950-08-4 | Details |
| Valsartan n-Propyl | C23H27N5O3 | 952652-79-8 | Details |
| 3-Ethyl-1-vinylimidazolium Bis(trifluoromethanesulfonyl)imide | C9H11F6N3O4S2 | 319476-28-3 | Details |
| Carnosic acid | C20H28O4 | 3650-09-7 | Details |
| Menadione | C11H8O2 | 58-27-5 | Details |
| Dostarlimab | 2022215-59-2 | Details |
| Romosozumab | 909395-70-6 | Details |
| Etrolizumab | 1044758-60-2 | Details |
| Monalizumab | 1228763-95-8 | Details |
| Relatlimab | 1673516-98-7 | Details |
| Disitamab Vedotin | 2136633-23-1 | Details |
| Vitamin D3 | C27H44O | 67-97-0 | Details |
| Anetumab Ravtansine | 1954758-84-9 | Details |
| ARGINASE | 9000-96-8 | Details |
| DBCO-Acid | C19H15NO3 | 1353016-70-2 | Details |
| 1-vinyl-3-ethylimidazolium bis(trifluoroethylimidazolium sulfonyl)imide | C9H11F6N3O4S2 | 204854-22-8 | Details |
| Aducanumab | 1384260-65-4 | Details |
| Meglumine | C7H17NO5 | 6284-40-8 | Details |
| bimekizumab | 1418205-77-2 | Details |
| Verteporfin | 2C41H42N4O8 | 129497-78-5 | Details |
| 1-ALLYL-3-ETHYLIMIDAZOLIUM BROMIDE | C8H13BrN2 | 652134-09-3 | Details |
| Immobilized penicillin G acylase | Details |
| Admire | C9H10ClN5O2 | 105827-78-9 | Details |
| Utomilumab | 1417318-27-4 | Details |
| Frunevetmab | 1708936-80-4 | Details |
| Leronlimab | 674782-26-4 | Details |
| (4S)-3-[(5R)-5-(4-FLUOROPHENYL)-5-HYDROXYPENTANOYL]-4-PHENYL-1,3-OXAZOLIDIN-2-ONE | C20H20FNO4 | 189028-95-3 | Details |
| 1,3,6,8-PYRENETETRASULFONIC ACID TETRASODIUM SALT | C16H11NaO12S4 | 59572-10-0 | Details |
| Sparfloxacin | C19H22F2N4O3 | 110871-86-8 | Details |
| Vinblastine sulfate | C46H60N4O13S | 143-67-9 | Details |
| Fipronil | C12H4Cl2F6N4OS | 120068-37-3 | Details |
| 8-Amino-1-naphthol-3,6-disulfonic acid monosodium salt monohydrate | C10H10NNaO7S2 | 5460-09-3 | Details |
| Teprotumumab | 1036734-93-6 | Details |
| Oxelumab | 1186098-83-8 | Details |
| Pepinemab | 2097151-87-4 | Details |
| 4-CYANOPHENYL ISOTHIOCYANATE | C8H4N2S | 2719-32-6 | Details |
| Cetuximab | C107H179N35O36S7 | 205923-56-4 | Details |
| Denosumab | C6404H9912N1724O2004S50 | 615258-40-7 | Details |
| Methyl (2S,3S,4S,5S,6S)-6-{[(1S,2S,3S,4R,5R)-3-( acetyloxy)-4-azido-6,8-dioxabicyclo[3.2.1]oct-2-yl]Methyl}-4 | C29H33N3O11 | 99541-26-1 | Details |
| Isonicotinamide | C6H6N2O | 1453-82-3 | Details |
| Atezolizumab | 1380723-44-3 | Details |
| Urelumab | 934823-49-1 | Details |
| L-Hydroxyproline | C5H9NO3 | 51-35-4 | Details |
| Bleomycin sulfate | C110H168N34O46S7 | 9041-93-4 | Details |
| Olaratumab | 1024603-93-7 | Details |
| S-GBOXIN | C27H32F3IN2O2 | 2101317-21-7 | Details |
| Cyclic AMP | C10H12N5O6P | 60-92-4 | Details |
| Vinorelbine tartrate | C53H66N4O20 | 125317-39-7 | Details |
| α-D-Glucopyranose, 2-azido-2-deoxy-3,4-bis-O-(phenylmethyl)-, 6-acetate | C22H25N3O6 | 61135-01-1 | Details |
| OBRINDATAMAB | 2069959-72-2 | Details |
| Vincristine sulfate | C46H58N4O14S | 2068-78-2 | Details |
| Immobilized Deacetylase | C24H31FO6 | Details |
| Etigilimab | 2044984-83-8 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||